NEW YORK (Reuters) -Online weight-loss company Noom has begun offering smaller doses of compounded versions of Novo Nordisk's ...

Eli Lilly plans to pursue approval for its new GLP-1 pill by the end of this year. Fact checked by Nick Blackmer A daily pill ...

Pharma giant Eli Lilly’s weight loss drug Mounjaro is priced between Rs. 10,000- ₹15,000 in India making it inaccessible to a ...

Sending weight loss jabs in the post to 15 million people could boost economic growth by £52 billion, according to a report by Sir Tony Blair ’s think tank. At such a critical moment in US history, we ...

Tirzepatide (Zepbound) led to more weight loss than semaglutide (Wegovy) in a clinical trial funded by Eli Lilly.

Novo Nordisk announced it is making the popular weight loss medication available ... with Type 2 diabetes. ABC News' Dr. Darien Sutton discusses the rise of GLP-1 weight loss drugs, when to ...

In 'Diet, Drugs, and Dopamine,' former FDA Commissioner David A. Kessler offers a comprehensive guide to weight loss.

Compounding pharmacies are supposed to stop producing the compounded versions of the popular weight loss medications now that ...

Scientists herald 150 new jabs and pills to tackle obesity going through the research pipeline - but issue urgent warning to ...